Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;33(4):324-330.
doi: 10.2337/ds19-0039.

Barriers to Continuous Glucose Monitoring in People With Type 1 Diabetes: Clinician Perspectives

Affiliations

Barriers to Continuous Glucose Monitoring in People With Type 1 Diabetes: Clinician Perspectives

Monica S Lanning et al. Diabetes Spectr. 2020 Nov.

Abstract

The purpose of this study was to determine clinician attitudes about the distinct barriers to uptake of continuous glucose monitoring (CGM) among people with diabetes. Survey data were collected measuring individual barriers, prerequisites to CGM, confidence in addressing barriers, and clinic staff resources. Results show that clinicians commonly report barriers to using CGM among people with diabetes in their clinic. Furthermore, clinicians who report a high number of barriers do not feel confident in overcoming the barriers to CGM. Interventions that attempt to empower clinicians to address concerns about CGM among people with diabetes may be warranted because low uptake does not appear to be directly related to available resources or prerequisites to starting CGM.

PubMed Disclaimer

References

    1. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26:1079–1087 - PubMed
    1. Hermanides J, Phillip M, DeVries JH. Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons. Diabetes Care 2011;34(Suppl. 2):S197–S201 - PMC - PubMed
    1. Rubin RR, Peyrot M. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. J Diabetes Sci Technol 2009;3:1402–1410 - PMC - PubMed
    1. Lukács A, Sasvári P, Török A, Barkai L. Generic and disease-specific quality of life in adolescents with type 1 diabetes: comparison to age-matched healthy peers. J Pediatr Endocrinol Metab 2016;29:769–775 - PubMed
    1. McGrady ME, Laffel L, Drotar D, Repaske D, Hood KK. Depressive symptoms and glycemic control in adolescents with type 1 diabetes: mediational role of blood glucose monitoring. Diabetes Care 2009;32:804–806 - PMC - PubMed